Blockade of the malignant phenotype by β-subunit selective noncovalent inhibition of immuno- and constitutive proteasomes.
Saved in:
| Title: | Blockade of the malignant phenotype by β-subunit selective noncovalent inhibition of immuno- and constitutive proteasomes. |
|---|---|
| Authors: | Villoutreix BO; INSERM, U 973, Université Paris Diderot, Sorbonne Paris Cité, Paris, France., Khatib AM; INSERM, LAMC, U 1029, Pessac, France., Cheng Y; Sorbonne Universités, UPMC Université Paris 6, UMR 8256, ERL U1164, B2A, IBPS, Paris, France., Miteva MA; INSERM, U 973, Université Paris Diderot, Sorbonne Paris Cité, Paris, France., Maréchal X; Sorbonne Universités, UPMC Université Paris 6, UMR 8256, ERL U1164, B2A, IBPS, Paris, France., Vidal J; Institut des Sciences Chimiques de Rennes, Université de Rennes 1, UMR-CNRS 6226, Rennes, France., Reboud-Ravaux M; Sorbonne Universités, UPMC Université Paris 6, UMR 8256, ERL U1164, B2A, IBPS, Paris, France. |
| Source: | Oncotarget [Oncotarget] 2017 Feb 07; Vol. 8 (6), pp. 10437-10449. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1949-2553 |
|---|---|
| DOI: | 10.18632/oncotarget.14428 |
